MAPT and Alzheimer disease: Yang et al. (76) conducted a quantitative succinylation proteomics analysis and found that mitochondrial proteins in AD patient brain tissue exhibited broadly reduced succinylation levels, while specific succinylation increases were observed at the APP K612 and tau K311 sites.